Stay updated on Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, indicating a minor site/template update.
    Difference
    0.1%
    Check dated 2026-05-15T15:29:47.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page revision label was updated from **v3.5.2** to **v3.5.3**, indicating a newer site/application version for the same study record.
    Difference
    0.1%
    Check dated 2026-04-24T05:58:40.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:28:56.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:53:17.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T23:53:29.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Added site navigation/footer elements for Moffitt Clinical Trials, the sponsoring institution, Helpful Links, and access to drug/device information and study documents.
    Difference
    0.3%
    Check dated 2026-02-25T18:25:57.000Z thumbnail image

Stay in the know with updates to Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page.